Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in frozen human plasma

Journal of Lipid Research

Volumn 58, Issue 12, 2017, Pages 2275-2288

  Bowden, John A ^a   Heckert, Alan ^a   Ulmer, Candice Z ^a   Jones, Christina M ^a   Koelmel, Jeremy P ^b   Abdullah, Laila ^c   Ahonen, Linda ^d   Alnouti, Yazen ^e   Armando, Aaron M ^f   Asara, John M ^g,h   Bamba, Takeshi ⁱ   Barr, John R ^j   Bergquist, Jonas ^k   Borchers, Christoph H ^l,m,n,o   Brandsma, Joost ^p   Breitkopf, Susanne B ^g   Cajka, Tomas ^q   Cazenave Gassiot, Amaury ^r   Checa, Antonio ^s   Cinel, Michelle A ^t   Colas, Romain A ^u   Cremers, Serge ^v   Dennis, Edward A ^b   Evans, James E ^c   Fauland, Alexander ^s   Fiehn, Oliver ^q,w   Gardner, Michael S ^j   Garrett, Timothy J ^b   Gotlinger, Katherine H ^x   Han, Jun ^l   Huang, Yingying ^y   Neo, Aveline Huipeng ^r   Hyötyläinen, Tuulia ^z   Izumi, Yoshihiro ⁱ   Jiang, Hongfeng ^v   Jiang, Houli ^x   Jiang, Jiang ^b   Kachman, Maureen ^aa   Kiyonami, Reiko ^y   Klavins, Kristaps ^ab   Klose, Christian ^ac   Köfeler, Harald C ^ad   Kolmert, Johan ^s   Koal, Therese ^ab   Koster, Grielof ^p   Kuklenyik, Zsuzsanna ^j   Kurland, Irwin J ^ae   Leadley, Michael ^af   Lin, Karen ^l   Maddipati, Krishna Rao ^ag   McDougall, Danielle ^b   Meikle, Peter J ^t   Mellett, Natalie A ^t   Monnin, Cian ^ah   Moseley, M Arthur ^ai   Nandakumar, Renu ^v   Oresic, Matej ^aj   Patterson, Rainey ^af   Peake, David ^y   Pierce, Jason S ^ak   Post, Martin ^af   Postle, Anthony D ^p   Pugh, Rebecca ^a   Qiu, Yunping ^ae   Quehenberger, Oswald ^f   Ramrup, Parsram ^al   Rees, Jon ^j   Rembiesa, Barbara ^ak   Reynaud, Denis ^af   Roth, Mary R ^ag   Sales, Susanne ^al   Schuhmann, Kai ^am   Schwartzman, Michal Laniado ^x   Serhan, Charles N ^u   Shevchenko, Andrej ^am   Somerville, Stephen E ^am   St John Williams, Lisa ^am   Surma, Michal A ^aj   Takeda, Hiroaki ⁱ   Thakare, Rhishikesh ^e   Thompson, J Will ^am   Torta, Federico ^r   Triebl, Alexander ^ad   Trötzmüller, Martin ^af   Ubhayasekera, S J Kumari ^k   Vuckovic, Dajana ^al   Weir, Jacquelyn M ^t   Welti, Ruth ^z   Wenk, Markus R ^r   Wheelock, Craig E ^s   Yao, Libin ^z   Yuan, Min ^g   Zhao, Xueqing Heather ^ae   Zhou, Senlin ^z   more..

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c ROSKAMP INSTITUTE   (United States)

^d STENO DIABETES CENTER   (Denmark)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^k UPPSALA UNIVERSITY   (Sweden)

^l UNIVERSITY OF VICTORIA   (Canada)

^m UNIVERSITY OF VICTORIA   (Canada)

ⁿ MCGILL UNIVERSITY   (Canada)

^o MCGILL UNIVERSITY   (Canada)

^p UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^q NATIONAL INSTITUTES OF HEALTH   (United States)

^r NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^s KAROLINSKA INSTITUTE   (Sweden)

^t BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^u BRIGHAM AND WOMEN S HOSPITAL   (United States)

^v Department of Medicine   (United States)

^w KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^x NEW YORK MEDICAL COLLEGE   (United States)

^y Thermo Fisher Scientific   (United States)

^z ÖREBRO UNIVERSITY   (Sweden)

^aa UNIVERSITY OF MICHIGAN   (United States)

^ab BIOCRATES LIFE SCIENCES AG   (Austria)

^ac LIPOTYPE GMBH   (Germany)

^ad MEDICAL UNIVERSITY OF GRAZ   (Austria)

^ae ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^af HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^ag WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ah Dept of Electrical and Computer Engineering   (Canada)

^ai DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aj UNIVERSITY OF TURKU   (Finland)

^ak MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^al KANSAS STATE UNIVERSITY   (United States)

^am MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

more..

Author keywords

Fatty acyls; Glycerolipids; Lipids; National institute of standards and technology; Phospholipids; Quality control; Quantitation; Sphingolipids; Standard reference material 1950; Sterols

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; LIMIT OF QUANTITATION; LIPIDOMICS; MASS SPECTROMETRY; MEASUREMENT ACCURACY; PERSONALIZED MEDICINE; PLASMA; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; BENCHMARKING; BLOOD; GOOD LABORATORY PRACTICE; INTERNATIONAL COOPERATION; LIPID METABOLISM; OBSERVER VARIATION; PHYSIOLOGY; REPRODUCIBILITY; STANDARD; STANDARDS; STATISTICS AND NUMERICAL DATA;

LIPID;

BENCHMARKING; HUMANS; INTERNATIONAL COOPERATION; LABORATORY PROFICIENCY TESTING; LIPID METABOLISM; LIPIDS; OBSERVER VARIATION; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 85037028318     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.m079012     Document Type: Article

References (78)

1. Burr, G. O., and M. M. Burr. 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 82: 345-367.
2. Burr, G. O., and M. M. Burr. 1930. On the nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 86: 587-621.
3. Steinberg, D. 2004. An interpretive history of the cholesterol controversy: part I. J. Lipid Res. 45: 1583-1593.
4. Steinberg, D. 2005. An interpretive history of the cholesterol controversy: part II: The early evidence linking hypercholesterolemia to coronary disease in humans. J. Lipid Res. 46: 179-190.
5. Wilson, P. W. 2013. Lipids and vascular disease: A Framingham perspective. Glob. Heart. 8: 25-33.
6. Blanksby, S. J., and T. W. Mitchell. 2010. Advances in mass spectrometry for lipidomics. Annu. Rev. Anal. Chem. (Palo Alto Calif). 3: 433-465.
7. Harkewicz, R., and E. A. Dennis. 2011. Applications of mass spectrometry to lipids and membranes. Annu. Rev. Biochem. 80: 301-325.
8. Quehenberger, O., and E. A. Dennis. 2011. The human plasma lipidome. N. Engl. J. Med. 365: 1812-1823.
9. Murphy, S. A., and A. Nicolaou. 2013. Lipidomics applications in health, disease and nutrition research. Mol. Nutr. Food Res. 57: 1336-1346.
10. Hu, C., R. van der Heijden, M. Wang, J. van der Greef, T. Hankemeier, and G. Xu. 2009. Analytical strategies in lipidomics and applications in disease biomarker discovery. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2836-2846.
11. Yang, L., M. Li, Y. Shan, S. Shen, Y. Bai, and H. Liu. 2016. Recent advances in lipidomics for disease research. J. Sep. Sci. 39: 38-50.
12. Dennis, E. A., H. A. Brown, R. A. Deems, C. K. Glass, A. H. Merrill, R. C. Murphy, R. H. Raetz, W. Shaw, S. Subramaniam, D. W. Russell, et al. 2005. The LIPID MAPS approach to lipidomics. In Functional Lipidomics. L. Feng and G. Prestwich, editors. CRC Press, Boca Raton, FL. 1-16.
13. Dennis, E. A. 2009. Lipidomics joins the omics evolution. Proc. Natl. Acad. Sci. USA. 106: 2089-2090.
14. Quehenberger, O., A. M. Armando, A. H. Brown, S. B. Milne, D. S. Myers, A. H. Merrill, S. Bandyopadhyay, K. N. Jones, S. Kelly, and R. L. Shaner. 2010. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51: 3299-3305.
15. Cajka, T., and O. Fiehn. 2014. Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends Analyt. Chem. 61: 192-206.
16. Gallart-Ayala, H., F. Courant, S. Severe, J-P. Antignac, F. Morio, J. Abadie, and B. Le Bizec. 2013. Versatile lipid profiling by liquid chromatography-high resolution mass spectrometry using all ion fragmentation and polarity switching. Preliminary application for serum samples phenotyping related to canine mammary cancer. Anal. Chim. Acta. 796: 75-83.
17. Yamada, T., T. Uchikata, S. Sakamoto, Y. Yokoi, E. Fukusaki, and T. Bamba. 2013. Development of a lipid profiling system using reverse- phase liquid chromatography coupled to high-resolution mass spectrometry with rapid polarity switching and an automated lipid identification software. J. Chromatogr. A. 1292: 211-218.
18. Cajka, T., and O. Fiehn. 2016. Toward merging untargeted and targeted methods in mass spectrometry-based metabolomics and lipidomics. Anal. Chem. 88: 524-545.
19. Hyötyläinen, T., and M. Orešič. 2016. Bioanalytical techniques in nontargeted clinical lipidomics. Bioanalysis. 8: 351-364.
20. Gross, R. W., and X. Han. 2011. Lipidomics at the interface of structure and function in systems biology. Chem. Biol. 18: 284-291.
21. Shevchenko, A., and K. Simons. 2010. Lipidomics: coming to grips with lipid diversity. Nat. Rev. Mol. Cell Biol. 11: 593-598.
22. Ekroos, K., M. Jänis, K. Tarasov, R. Hurme, and R. Laaksonen. 2010. Lipidomics: A tool for studies of atherosclerosis. Curr. Atheroscler. Rep. 12: 273-281.
23. Auffray, C., T. Caulfield, J. L. Griffin, M. J. Khoury, J. R. Lupski, and M. Schwab. 2016. From genomic medicine to precision medicine: highlights of 2015. Genome Med. 8: 12.
24. Clish, C. B. 2015. Metabolomics: An emerging but powerful tool for precision medicine. Cold Spring Harb. Mol. Case Stud. 1: A000588.
25. Loomba, R., O. Quehenberger, A. Armando, and E. A. Dennis. 2015. Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis. J. Lipid Res. 56: 185-192.
26. Gorden, D. L., D. S. Myers, P. T. Ivanova, E. Fahy, M. R. Maurya, S. Gupta, J. Min, N. J. Spann, J. G. McDonald, S. L. Kelly, et al. 2015. Biomarkers of NAFLD progression: A lipidomics approach to an epidemic. J. Lipid Res. 56: 722-736.
27. Teo, C. C., W. P. K. Chong, E. Tan, N. B. Basri, Z. J. Low, and Y. S. Ho. 2015. Advances in sample preparation and analytical techniques for lipidomics study of clinical samples. Trends Analyt. Chem. 66: 1-18.
28. Vesper, H. W., G. L. Myers, and W. G. Miller. 2016. Current practices and challenges in the standardization and harmonization of clinical laboratory tests. Am. J. Clin. Nutr. 104: 907S-912S.
29. McShane, L. M., M. M. Cavenagh, T. G. Lively, D. A. Eberhard, W. L. Bigbee, P. M. Williams, J. P. Mesirov, M-Y. C. Polley, K. Y. Kim, and J. V. Tricoli. 2013. Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration. BMC Med. 11: 220.
30. Ekroos, K. 2012. Lipidomics perspective: from molecular lipidomics to validated clinical diagnostics. In Lipidomics: Technologies and Applications. K. Ekroos, editor. Wiley-VCH, Weinheim, Germany. 1-19.
31. Hyötyläinen, T., and M. Orešič. 2015. Optimizing the lipidomics workflow for clinical studies-practical considerations. Anal. Bioanal. Chem. 407: 4973-4993.
32. Bou Khalil, M., W. Hou, H. Zhou, F. Elisma, L. A. Swayne, A. P. Blanchard, Z. Yao, S. A. Bennett, and D. Figeys. 2010. Lipidomics era: Accomplishments and challenges. Mass Spectrum. Rev. 29: 877-929.
33. Köfeler, H. C., A. Fauland, G. N. Rechberger, and M. Trötzmüller. 2012. Mass spectrometry based lipidomics: An overview of technological platforms. Metabolites. 2: 19-38.
34. Li, M., L. Yang, Y. Bai, and H. Liu. 2014. Analytical methods in lipidomics and their applications. Anal. Chem. 86: 161-175.
35. Reis, A., A. Rudnitskaya, G. J. Blackburn, N. M. Fauzi, A. R. Pitt, and C. M. Spickett. 2013. A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL. J. Lipid Res. 54: 1812-1824.
36. Paulovich, A. G., D. Billheimer, A-J. L. Ham, L. Vega-Montoto, P. A. Rudnick, D. L. Tabb, P. Wang, R. K. Blackman, D. M. Bunk, and H. L. Cardasis. 2010. Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol. Cell. Proteomics. 9: 242-254.
37. Percy, A. J., J. Tamura-Wells, J. P. Albar, K. Aloria, A. Amirkhani, G. D. T. Araujo, J. M. Arizmendi, F. J. Blanco, F. Canals, J. Y. Cho, et al. 2015. Inter-laboratory evaluation of instrument platforms and experimental workflows for quantitative accuracy and reproducibility assessment. EuPA Open Proteom. 8: 6-15.
38. Abbatiello, S. E., B. Schilling, D. R. Mani, L. J. Zimmerman, S. C. Hall, B. MacLean, M. Albertolle, S. Allen, M. Burgess, M. P. Cusack, et al. 2015. Large-scale interlaboratory study to develop, analytically validate and apply highly multiplexed, quantitative peptide assays to measure cancer-relevant proteins in plasma. Mol. Cell. Proteomics. 14: 2357-2374.
39. Bennett, K. L., X. Wang, C. E. Bystrom, M. C. Chambers, T. M. Andacht, L. J. Dangott, F. Elortza, J. Leszyk, H. Molina, R. L. Moritz, et al. 2015. The 2012/2013 ABRF Proteomic Research Group Study: Assessing longitudinal intralaboratory variability in routine peptide liquid chromatography tandem mass spectrometry analyses. Mol. Cell. Proteomics. 14: 3299-3309.
40. Siskos, A. P., P. Jain, W. Römisch-Margl, M. Bennett, D. Achaintre, Y. Asad, L. Marney, L. Richardson, A. Koulman, J. L. Griffin, et al. 2017. Interlaboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma. Anal. Chem. 89: 656-665.
41. Viant, M. R., D. W. Bearden, J. G. Bundy, I. W. Burton, T. W. Collette, D. R. Ekman, V. Ezernieks, T. K. Karakach, C. Y. Lin, S. Rochfort, et al. 2009. International NMR-based environmental metabolomics intercomparison exercise. Environ. Sci. Technol. 43: 219-225.
42. Cheema, A. K., J. M. Asara, Y. Wang, T. A. Neubert, V. Tolstikov, and C. W. Turck. 2015. The ABRF Metabolomics Research Group 2013 Study: investigation of spiked compound differences in a human plasma matrix. J. Biomol. Tech. 26: 83-89.
43. Martin, J-C., M. Maillot, G. Mazerolles, A. Verdu, B. Lyan, C. Migné, C. Defoort, C. Canlet, C. Junot, C. Guillou, et al. 2015. Can we trust untargeted metabolomics? Results of the metabo-ring initiative, a large-scale, multi-instrument inter-laboratory study. Metabolomics. 11: 807-821.
44. Ivanov, A. R., C. M. Colangelo, C. P. Dufresne, D. B. Friedman, K. S. Lilley, K. Mechtler, B. S. Phinney, K. L. Rose, P. A. Rudnick, and B. C. Searle. 2013. Interlaboratory studies and initiatives developing standards for proteomics. Proteomics. 13: 904-909.
45. Sumner, L. W., A. Amberg, D. Barrett, M. H. Beale, R. Beger, C. A. Daykin, T. W-M. Fan, O. Fiehn, R. Goodacre, and J. L. Griffin. 2007. Proposed minimum reporting standards for chemical analysis. Metabolomics. 3: 211-221.
46. Fiehn, O., B. Kristal, B. V. Ommen, L. W. Sumner, S-A. Sansone, C. Taylor, N. Hardy, and R. Kaddurah-Daouk. 2006. Establishing reporting standards for metabolomic and metabonomic studies: A call for participation. OMICS. 10: 158-163.
47. Beger, R. D., W. Dunn, M. A. Schmidt, S. S. Gross, J. A. Kirwan, M. Cascante, L. Brennan, D. S. Wishart, M. Oresic, and T. Hankemeier. 2016. Metabolomics enables precision medicine: "a white paper, community perspective. Metabolomics. 12: 149.
48. Phinney, K. W., G. Ballihaut, M. Bedner, B. S. Benford, J. E. Camara, S. J. Christopher, W. C. Davis, N. G. Dodder, G. Eppe, and B. E. Lang. 2013. Development of a standard reference material for metabolomics research. Anal. Chem. 85: 11732-11738.
49. Simón-Manso, Y., M. S. Lowenthal, L. E. Kilpatrick, M. L. Sampson, K. H. Telu, P. A. Rudnick, W. G. Mallard, D. W. Bearden, T. B. Schock, D. V. Tchekhovskoi, et al. 2013. Metabolite profiling of a NIST standard reference material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. Anal. Chem. 85: 11725-11731.
50. Koal, T., and H-P. Deigner. 2010. Challenges in mass spectrometry based targeted metabolomics. Curr. Mol. Med. 10: 216-226.
51. Telu, K. H., X. Yan, W. E. Wallace, S. E. Stein, and Y. Simón-Manso. 2016. Analysis of human plasma metabolites across different liquid chromatography/mass spectrometry platforms: cross-platform transferable chemical signatures. Rapid Commun. Mass Spectrom. 30: 581-593.
52. Colas, R. A., M. Shinohara, J. Dalli, N. Chiang, and C. N. Serhan. 2014. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am. J. Physiol. Cell Physiol. 307: C39-C54.
53. National Institute of Standards and Technology. 2012. Certificate of Analysis: Standard Reference Material 1950 - Metabolites in Human Plasma. Accessed July 5, 2017, at https://www-s.nist.gov/srmors/view-cert.cfm?srm=1950.
54. Bowden, J. A., A. Heckert, C. Z. Ulmer, C. M. Jones, and R. S. Pugh. 2017. NISTIR 8185. Lipid concentrations in Standard Reference Material (SRM) 1950: results from an interlaboratory comparison exercise for lipidomics. Accessed August 2, 2017, at http://nvlpubs.nist.gov/nistpubs/ir/2017/NIST.IR.8185.pdf.
55. Ulmer, C. Z., J. P. Koelmel, J. M. Ragland, T. J. Garrett, and J. A. Bowden. 2017. LipidPioneer: A comprehensive user-generated exact mass template for lipidomics. J. Am. Soc. Mass Spectrom. 28: 562-565.
56. Liebisch, G., J. A. Vizcaino, H. Köfeler, M. Trötzmüller, W. J. Griffiths, G. Schmitz, F. Spener, and M. J. Wakelam. 2013. Shorthand notation for lipid structures derived from mass spectrometry. J. Lipid Res. 54: 1523-1530.
57. Heckert, A., and J. J. Filliben. 2016. Dataplot Reference Manual Volume I: Commands. Accessed February 2, 2017, at http://www.itl.nist.gov/div898/software/dataplot/refman1/homepage.htm.
58. CCQM. 2013. CCQM guidance note: estimation of a consensus KCRV and associated degrees of equivalence. Version 10. Accessed February 2, 2017, at https://www.bipm.org/cc/CCQM/Allowed/19/CCQM13-22-Consensus-KCRV-v10.pdf.
59. Bonett, D. G., and E. Seier. 2006. Confidence interval for a coefficient of dispersion in nonnormal distributions. Biom. J. 48: 144-148.
60. Rukhin, A. L., and M. G. Vangel. 1998. Estimation of a common mean and weighted means statistics. J. Am. Stat. Assoc. 93: 303-308.
61. Vangel, M. G., and A. L. Rukhin. 1999. Maximum likelihood analysis for heteroscedastic one-way random effects ANOVA in interlaboratory studies. Biometrics. 55: 129-136.
62. DerSimonian, R., and N. Laird. 1986. Meta-Analysis in clinical trials. Control. Clin. Trials. 7: 177-188.
63. Fahy, E., S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill, R. C. Murphy, C. R. Raetz, D. W. Russell, Y. Seyama, W. Shaw, et al. 2005. A comprehensive classification system for lipids. J. Lipid Res. 46: 839-861.
64. Fahy, E., S. Subramaniam, R. C. Murphy, M. Nishijima, C. R. Raetz, T. Shimizu, F. Spener, G. van Meer, M. J. Wakelam, and E. A. Dennis. 2009. Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 50: S9-S14.
65. Sales, S., J. Graessler, S. Ciucci, R. Al-Atrib, T. Vihervaara, K. Schuhmann, D. Kauhanen, M. Sysi-Aho, S. R. Bornstein, and M. Bickle. 2016. Gender, contraceptives and individual metabolic predisposition shape a healthy plasma lipidome. Sci. Rep. 6: 27710.
66. Qu, F., S-J. Zheng, C-S. Wu, Z-X. Jia, J-L. Zhang, and Z-P. Duan. 2014. Lipidomic profiling of plasma in patients with chronic hepatitis C infection. Anal. Bioanal. Chem. 406: 555-564.
67. Koelmel, J. P., N. M. Kroeger, E. L. Gill, C. Z. Ulmer, J. A. Bowden, R. E. Patterson, R. A. Yost, and T. J. Garrett. 2017. Expanding lipidome coverage using LC-MS/MS data-dependent acquisition with automated exclusion list generation. J. Am. Soc. Mass Spectrom. 28: 908-917.
68. Surma, M. A., R. Herzog, A. Vasilj, C. Klose, N. Christinat, D. Morin-Rivron, K. Simons, M. Masoodi, and J. L. Sampaio. 2015. An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids. Eur. J. Lipid Sci. Technol. 117: 1540-1549.
69. Jung, H. R., T. Sylvänne, K. M. Koistinen, K. Tarasov, D. Kauhanen, and K. Ekroos. 2011. High throughput quantitative molecular lipidomics. Biochim. Biophys. Acta. 1811: 925-934.
70. Ovčačíková, M., M. Lísa, E. Cífková, and M. Holčapek. 2016. Retention behavior of lipids in reversed-phase ultrahigh-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. A. 1450: 76-85.
71. Meikle, P. J., G. Wong, D. Tsorotes, C. K. Barlow, J. M. Weir, M. J. Christopher, G. L. MacIntosh, B. Goudey, L. Stern, and A. Kowalczyk. 2011. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 31: 2723-2732.
72. Cajka, T., and O. Fiehn. 2016. Increasing lipidomic coverage by selecting optimal mobile-phase modifiers in LC-MS of blood plasma. Metabolomics. 12: 1-11.
73. Sharpless, K. E., K. A. Lippa, D. L. Duewer, and A. L. Rukhin. 2015. The ABCs of Using Standard Reference Materials in the Analysis of Foods and Dietary Supplements: A Practical Guide. NIST Special Publication: sp260-181rev1. Accessed February 2, 2017, at http://nvlpubs.nist.gov/nistpubs/SpecialPublications/NIST.SP.260-181.pdf.
74. Breitkopf, S. B., S. J. H. Ricoult, M. Yuan, Y. Xu, D. A. Peake, B. D. Manning, and J. M. Asara. 2017. A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC-MS/MS from any biological source. Metabolomics. 13: 30.
75. Cífková, E., M. Holčapek, M. Lísa, M. Ovčačíková, A. Lyčka, F. Lynen, and P. Sandra. 2012. Nontargeted quantitation of lipid classes using hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry with single internal standard and response factor approach. Anal. Chem. 84: 10064-10070.
76. Yang, K., and X. Han. 2011. Accurate quantification of lipid species by electrospray ionization mass spectrometry-meets a key challenge in lipidomics. Metabolites. 1: 21-40.
77. Koivusalo, M., P. Haimi, L. Heikinheimo, R. Kostiainen, and P. Somerharju. 2001. Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J. Lipid Res. 42: 663-672.
78. Murphy, R. C., J. Fiedler, and J. Hevko. 2001. Analysis of nonvolatile lipids by mass spectrometry. Chem. Rev. 101: 479-526.